The Government has approved two more Covid-19 vaccines and an anti-viral drug for use in India. The approvals will give a major boost to India’s massive vaccination drive against coronavirus.
Health Minister Dr. Mansukh Mandaviya said that the Central Drugs Standard Control Organisation (CDSCO) under the Ministry of Health and Family Welfare has given emergency use authorization approval to COVID-19 vaccines Covovax and Corbevax and Anti-viral drug Molnupiravir.
The approval comes a day after the Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) recommended granting emergency use authorisation for the above two vaccines and one anti-viral drug.
Covovax will be made by the Serum Institute of India (SII) while Biological-E will make the Corbevax vaccine.
Health minister Mandaviya said on Tuesday that Corbevax is the country’s first indigenously developed RBD protein sub-unit vaccine against Covid-19.
With this approval, the number of Covid vaccines which have received emergency use authorisation in the country has increased to eight.
Also Read: Ludhiana court blast-linked SFJ terrorist, Jaswinder Singh Multani detained in Germany
(With inputs from agencies)
